JOHNSON & JOHNSON — SC 13G/A Filings
84 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by JOHNSON & JOHNSON (JNJ), sorted by most recent first. Each row links to the full filing on EdgarLookup. JOHNSON & JOHNSON has filed 84 SC 13G/A documents with the SEC since 2018. To view all SEC filings by JOHNSON & JOHNSON, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
11-K
11-K/A
13F-HR
13F-HR/A
13F-NT
144
15-15D
25-NSE
3
3/A
4
4/A
424B2
424B3
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CERTNYS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFN14A
DFAN14A
EFFECT
FWP
N-PX
NO ACT
POS AM
PRE 14A
PX14A6G
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-4MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D1
SC 14D1/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000574 | Nov 1, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000536 | Oct 18, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000345 | May 20, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021263 | Feb 13, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000094 | Feb 2, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000092 | Feb 2, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-24-000096 | Feb 2, 2024 | — |
| SC 13G/A | — | 0001086364-24-004277 | Jan 26, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016270 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-005043 | Jan 31, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-23-000061 | Jan 27, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON | 0000904454-23-000019 | Jan 11, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-284369 | Nov 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017888 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000834237-22-003836 | Feb 1, 2022 | — |
| SC 13G/A | SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC. | 0000904454-22-000079 | Feb 1, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018422 | Feb 10, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000904454-21-000100 | Feb 2, 2021 | — |
| SC 13G/A | — | 0000834237-21-004788 | Jan 29, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018140 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000834237-20-008684 | Feb 10, 2020 | — |
| SC 13G/A | SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON, DATED 12.3 | 0000904454-20-000049 | Jan 17, 2020 | — |
| SC 13G/A | SCH 13GA - FILER JOHNSON & JOHNSON, SUBJECT - PROVENTION BIO, DTD 12/31/19 | 0000904454-20-000047 | Jan 17, 2020 | — |
| SC 13G/A | — | 0000932471-19-005120 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000215457-19-007262 | Feb 11, 2019 | — |
| SC 13G/A | SCHEDULE 13G-A FOR MACROGENICS, INC. BY JOHNSON & JOHNSON | 0000904454-19-000073 | Jan 22, 2019 | — |
| SC 13G/A | SCHEDULE 13G-A FOR MERUS N.V. BY JOHNSON & JOHNSON | 0000904454-19-000075 | Jan 22, 2019 | — |
| SC 13G/A | SCHEDULE 13G-A FOR ADURO BIOTECH, INC. BY JOHNSON & JOHNSON | 0000904454-19-000071 | Jan 22, 2019 | — |
| SC 13G/A | SCHEDULE 13G-A FOR GI DYNAMICS, INC. BY JOHNSON & JOHNSON | 0000904454-19-000067 | Jan 22, 2019 | — |
| SC 13G/A | SCHEDULE 13G-A FOR ALDEYRA THERAPEUTICS, INC. BY JOHNSON & JOHNSON | 0000904454-19-000069 | Jan 22, 2019 | — |
| SC 13G/A | — | 0000932471-18-003610 | Feb 9, 2018 | — |
| SC 13G/A | — | 0000215457-18-005105 | Feb 8, 2018 | — |
| SC 13G/A | SCHED13G/A SUBMITTED ON 1-16-18 FOR JOHNSON & JOHNSON AND TRACON PHARMACEUTICALS | 0000904454-18-000041 | Jan 22, 2018 | — |
| SC 13G/A | SCH13G/A RECEIVED IN DP ON 1-16-18 FOR JOHNSON & JOHNSON AND CATALYST BIOSCIENCE | 0000904454-18-000039 | Jan 22, 2018 | — |
| SC 13G/A | SC 13G/A FOR ACHILLION PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON | 0000904454-17-000690 | Nov 22, 2017 | — |
| SC 13G/A | FORM SC 13G/A FOR MINERVA NEUROSCIENCES, INC. BY JOHNSON & JOHNSON | 0000904454-17-000610 | Sep 14, 2017 | — |
| SC 13G/A | — | 0000932471-17-001197 | Feb 10, 2017 | — |
| SC 13G/A | — | 0000353480-17-001111 | Jan 25, 2017 | — |
| SC 13G/A | — | 0000904454-17-000051 | Jan 18, 2017 | — |
| SC 13G/A | SCHEDULE 13G/A FOR AQUINOX PHARMACEUTICALS | 0000904454-16-001000 | Feb 12, 2016 | — |
| SC 13G/A | SCHEDULE 13G/A FOR NEVRO CORP. | 0000904454-16-000998 | Feb 12, 2016 | — |
| SC 13G/A | SC 13G/A FOR MINERVA NEUROSCIENCES, INC. BY JOHNSON & JOHNSON | 0000904454-16-001002 | Feb 12, 2016 | — |
| SC 13G/A | SCHEDULE 13G/A FOR GENOCEA BIOSCIENCES | 0000904454-16-000991 | Feb 12, 2016 | — |
| SC 13G/A | — | 0000932471-16-010987 | Feb 10, 2016 | — |
| SC 13G/A | — | 0000215457-16-005634 | Feb 10, 2016 | — |
| SC 13G/A | — | 0000215457-15-000218 | Feb 9, 2015 | — |
| SC 13G/A | — | 0001086364-14-001083 | Jan 29, 2014 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000950157-13-000373 | Oct 10, 2013 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000950157-13-000153 | Apr 19, 2013 | — |
| SC 13G/A | S 13 G/A AMENDMENT NO. 3 - FOR JOHNSON & JOHNSON - UNIVERSAL BIOSENSORS INC. | 0000904454-13-000182 | Feb 12, 2013 | — |